Intraspinal grafting of fibroblasts genetically modified by recombinant adenoviruses - PubMed (original) (raw)

Intraspinal grafting of fibroblasts genetically modified by recombinant adenoviruses

Y Liu et al. Neuroreport. 1998.

Abstract

Intracerebral or intraspinal grafting of genetically modified primary fibroblasts has been shown to enhance functional recovery in several models of CNS disease, including spinal cord injury. Most of these studies utilized retrovirus vectors. In this report, we describe in vitro conditions for genetically modifying primary fibroblasts with recombinant adenovirus vectors carrying the lacZ or green fluorescent protein (GFP) genes. As intraspinal allografts in animals immunosuppressed by cyclosporin A, the genetically modified cells survived and expressed the transgenes for at least 2 months. We conclude that recombinant adenovirus vectors are efficient and convenient tools for ex vivo gene therapy in the CNS.

PubMed Disclaimer

Similar articles

• Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirus.
  Li JZ, Hankins GR, Kao C, Li H, Kammauff J, Helm GA. Li JZ, et al. J Gene Med. 2003 Sep;5(9):748-56. doi: 10.1002/jgm.412. J Gene Med. 2003. PMID: 12950065
• Transplants of cells genetically modified to express neurotrophin-3 rescue axotomized Clarke's nucleus neurons after spinal cord hemisection in adult rats.
  Himes BT, Liu Y, Solowska JM, Snyder EY, Fischer I, Tessler A. Himes BT, et al. J Neurosci Res. 2001 Sep 15;65(6):549-64. doi: 10.1002/jnr.1185. J Neurosci Res. 2001. PMID: 11550223
• Post-spinal cord injury astrocyte-mediated functional recovery in rats after intraspinal injection of the recombinant adenoviral vectors Ad5-VEGF and Ad5-ANG.
  Povysheva T, Shmarov M, Logunov D, Naroditsky B, Shulman I, Ogurcov S, Kolesnikov P, Islamov R, Chelyshev Y. Povysheva T, et al. J Neurosurg Spine. 2017 Jul;27(1):105-115. doi: 10.3171/2016.9.SPINE15959. Epub 2017 Apr 28. J Neurosurg Spine. 2017. PMID: 28452633
• Grafting of genetically modified fibroblasts into the injured spinal cord.
  Liu Y, Murray M, Tessler A, Fischer I. Liu Y, et al. Prog Brain Res. 2000;128:309-19. doi: 10.1016/S0079-6123(00)28028-X. Prog Brain Res. 2000. PMID: 11105690 Review. No abstract available.
• Ex vivo gene therapy for Alzheimer's disease and spinal cord injury.
  Blesch A, Tuszynski M. Blesch A, et al. Clin Neurosci. 1995-1996;3(5):268-74. Clin Neurosci. 1995. PMID: 8914793 Review.

Cited by

• Neural progenitor cells grown on hydrogel surfaces respond to the product of the transgene of encapsulated genetically engineered fibroblasts.
  Shanbhag MS, Lathia JD, Mughal MR, Francis NL, Pashos N, Mattson MP, Wheatley MA. Shanbhag MS, et al. Biomacromolecules. 2010 Nov 8;11(11):2936-43. doi: 10.1021/bm100699q. Epub 2010 Oct 13. Biomacromolecules. 2010. PMID: 20942395 Free PMC article.
• Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function.
  Liu Y, Kim D, Himes BT, Chow SY, Schallert T, Murray M, Tessler A, Fischer I. Liu Y, et al. J Neurosci. 1999 Jun 1;19(11):4370-87. doi: 10.1523/JNEUROSCI.19-11-04370.1999. J Neurosci. 1999. PMID: 10341240 Free PMC article.
• Endovascular treatment of experimental aneurysms by use of biologically modified embolic devices: coil-mediated intraaneurysmal delivery of fibroblast tissue allografts.
  Marx WE, Cloft HJ, Helm GA, Short JG, Do HM, Jensen ME, Kallmes DE. Marx WE, et al. AJNR Am J Neuroradiol. 2001 Feb;22(2):323-33. AJNR Am J Neuroradiol. 2001. PMID: 11156778 Free PMC article.
• A pilot study of poly(N-isopropylacrylamide)-g-polyethylene glycol and poly(N-isopropylacrylamide)-g-methylcellulose branched copolymers as injectable scaffolds for local delivery of neurotrophins and cellular transplants into the injured spinal cord.
  Conova L, Vernengo J, Jin Y, Himes BT, Neuhuber B, Fischer I, Lowman A, Vernengo J, Jin Y, Himes BT, Neuhuber B, Fischer I, Lowman A. Conova L, et al. J Neurosurg Spine. 2011 Dec;15(6):594-604. doi: 10.3171/2011.7.SPINE11194. Epub 2011 Sep 2. J Neurosurg Spine. 2011. PMID: 21888482 Free PMC article.
• Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition.
  Jones LL, Sajed D, Tuszynski MH. Jones LL, et al. J Neurosci. 2003 Oct 15;23(28):9276-88. doi: 10.1523/JNEUROSCI.23-28-09276.2003. J Neurosci. 2003. PMID: 14561854 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wolters Kluwer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program